The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), intends to negotiate a sole-source contract with Bruker Cellular Analysis, Inc. for the Beacon Essential Service Plan, which is crucial for the operational maintenance of the Beacon Optofluidic System. This system is integral to the research conducted by the Laboratory of Immunogenetics, focusing on the development of therapeutic monoclonal antibodies against influenza and other diseases, necessitating continuous maintenance and on-call service support. Interested parties capable of providing comparable services are invited to submit a capabilities statement via the NIAID electronic Simplified Acquisition Submission System (eSASS) by 12:00 PM EST on May 29, 2025, referencing NOI-NIAID-25-2259917. For further inquiries, contact Maliaka Pinkney at maliaka.pinkney@nih.gov or Jesse Weidow at weidowjd@niaid.nih.gov.